Photo: Depositphotos
Sep 22, 2025, 13:37
Pregnancy in Sickle Cell Disease: Addressing the Underrecognized Risk of Venous Thromboembolism
American Society of Hematology shared a post on LinkedIn:
“Pregnancy in sickle cell disease carries a high risk of thrombotic complications, yet guidance on anticoagulation remains inconsistent.
Chronic hypercoagulability and prior thrombotic events heighten these risks, making early recognition, individualized care, and preventive strategies essential.
Collaborative, multidisciplinary approaches and evidence-based anticoagulation protocols can help improve outcomes for this vulnerable population.”
Title: Venous Thromboembolism in Sickle Cell Disease: A Critical and Underrecognized Maternal Health Risk
Authors: Sacha Choupa
Read the full article here.
Stay updated with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action